Immunoglobulin Therapy: Clinical Trials

2 trials for Immunoglobulin Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 31Not yet recruiting 1

Follow Immunoglobulin Therapy: new trials by email Literature Review of Immunoglobulin Therapy trials Research Report on Immunoglobulin Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma
Immunoglobulin, antibiotic prophylaxis - Chimeric Antigen Receptor T-cell Therapy, B Cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris2282026-09-012026-08-10
Preventing Intravenous Immunoglobulin-associated Adverse Reactions
Infusomat filter (Codan Duofilter-Set V86-P), IVIG application without filter (Placebo) - Immunoglobulin Therapy
Not applicableCompletedUniversity Hospital, Basel, Switzerland422008-05-012014-09-22

Narrower conditions

Burkitt Lymphoma (1)  ·  Lymphoma, B-Cell (1)

Broader conditions

DNA Virus Infections (1)  ·  Epstein-Barr Virus Infections (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Herpesviridae Infections (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Infections (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Tumor Virus Infections (1)  ·  Virus Diseases (1)

Interventions

Antibiotic Prophylaxis (1)  ·  Immunoglobulins (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  University Hospital, Basel, Switzerland (1)

Countries

Switzerland (1)

Top investigators

Christoph Hess, MD (1)